Back

SGLT2i chronic treatment reduces cardiac hypertrophy and modulates left ventricle metabolome of a HFpEF animal model

20 January 2025 (15:00 - 14:00)
Organised by: Logo
Seminar Presentation Part of: Poster session Heart Failure with Preserved Ejection Fraction (HFpEF) Delegate Premium access HFA Winter Research Meeting on Translational Heart Failure 2025 Heart Failure Association (HFA)

About the speaker

Photo
Miss Maria Ines Nuno Alves

Faculty of Medicine University of Porto, Porto (Portugal)

35 More presentations in this session

Presentation thumbnail
Long-term survival and precisions phenotyping in patients with dilated cardiomyopathy
Doctor M. Wideqvist (Gothenburg, SE)
Abstract Slides
Presentation thumbnail
Multimodal predictive model for 6-month treatment-related cardiotoxicity in non-Hodgkin lymphoma patients
Doctor D. Bursacovschi (Chisinau, MD)
Abstract Slides
Presentation thumbnail
Preclinical model unveiling the remodeling mechanisms of post-ischemic heart failure:focus on SERCA2a Reactivation
Doctor L. Gomez (Bron, FR)
Abstract Slides
Presentation thumbnail
A transformative two-hit model: bridging metabolic dysfunction and hypertension in HFpEF
Mr I. Aykac (Vienna, AT)
Abstract Slides
Presentation thumbnail
Non-cell autonomous effects of Dnmt3a-mutant clonal haematopoiesis in ST-elevation myocardial infarction
Doctor D. Bromage (London, GB)
Abstract Slides

Access the full session

Session thumbnail
Poster session

The Event

Event poster

HFA Winter Research Meeting on Translational Heart Failure 2025

20 January - 22 January 2025

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources